Paragon 28 Operating Margin 2020-2022 | FNA
Current and historical operating margin for Paragon 28 (FNA) over the last 10 years. The current operating profit margin for Paragon 28 as of June 30, 2022 is -18.54%.
| Paragon 28 Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2022-06-30 | $0.16B | $-0.03B | -16.05% |
| 2022-03-31 | $0.16B | $-0.02B | -11.54% |
| 2021-12-31 | $0.15B | $-0.01B | -6.76% |
| 2021-06-30 | $0.10B | $0.00B | 3.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.486B | $0.147B |
| Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.578B | 23.18 |
| Edwards Lifesciences (EW) | United States | $62.887B | 44.49 |
| Alcon (ALC) | Switzerland | $36.987B | 31.32 |
| STERIS (STE) | Ireland | $20.913B | 25.96 |
| Teleflex (TFX) | United States | $11.693B | 18.63 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.936B | 10.09 |
| Globus Medical (GMED) | United States | $6.491B | 32.38 |
| Penumbra (PEN) | United States | $6.042B | 724.86 |
| Glaukos (GKOS) | United States | $2.370B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.345B | 18.34 |
| Nevro (NVRO) | United States | $1.688B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.365B | 20.90 |
| Artivion (AORT) | United States | $0.860B | 82.00 |
